AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Climbs 104.3%

AB Corporate Bond ETF (NASDAQ:EYEG) saw a large increase in short interest in October. As of October 15th, there was short interest totaling 950 shares, an increase of 104.3% from the September 30th total of 465 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 463 shares, the short-interest ratio is currently 2.1 days.

AB Corporate Bond ETF Stock Performance

Shares of NASDAQ EYEG traded up $0.01 during midday trading on Friday, hitting $33.88. The company’s stock had a trading volume of 904 shares, compared to its average volume of 556. AB Corporate Bond ETF has a 1-year low of $33.24 and a 1-year high of $36.46. The firm’s fifty day moving average price is $33.90 and its 200-day moving average price is $34.94. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07. The firm has a market cap of $27.10 million, a P/E ratio of -20.16 and a beta of 0.20.

AB Corporate Bond ETF Increases Dividend

The firm also recently disclosed a monthly dividend, which was paid on Tuesday, October 6th. Shareholders of record on Thursday, October 1st were paid a $0.1367 dividend. This is an increase from AB Corporate Bond ETF’s previous monthly dividend of $0.1284. This represents a $1.64 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend was Thursday, October 1st. AB Corporate Bond ETF’s payout ratio is presently -101.79%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.